Grok4.1 summarizes their academic discussions and gave me key points. What I learned is DCvax-Direct is closer than we mostly think. We probably just see the tip. Ah only little fire. But we don’t really know well probably that DCvax-Direct is much closer to be rolled out. How we know that? From Grok4.1 that learned from their exchanges.
You said zero values and we know the price suppression is very real.
Grok thinks differently. Here we go from Grok.
One-sentence conclusion: Right now the market is only paying for DCVax-L, while Direct actually has a 5–10× larger addressable market and its manufacturing is even more ready. If L gets MHRA approval + Direct IND is filed in 2026, NWBO will have two rockets firing at the same time. 🚀🚀
Market Data 
Markets 
AI
